1. Cardiomyopathy. Risk factors. Modern representation
   А. N. Chepurnaya, 2022, Clinical Medicine (Russian Journal) CrossRef
2. Comparison of Beta-Blocker Effectiveness in Heart Failure Patients With Preserved Ejection Fraction Versus Those With Reduced Ejection Fraction
   Mostafa El-Refai et al, 2013, Journal of Cardiac Failure CrossRef
3. Pharmacogenetics in Cardiovascular Diseases
   Larisa H. Cavallari et al, 2019, Pharmacogenomics CrossRef
4. Adrenergic Polymorphisms and Survival in African Americans With Heart Failure: Results From A-HeFT
   AMBER E. Johnson et al, 2019, Journal of Cardiac Failure CrossRef
5. Non‑synonymous polymorphisms in the HRC and ADRB1 genes may be associated with all‑cause death in patients with non‑ischemic heart failure
   Tanise Telles et al, 2023, Experimental and Therapeutic Medicine CrossRef
6. Pharmacogenomics in drug discovery and development
   Baldeep Singh et al, 2023, Pharmacogenomics CrossRef
7. Genomic ancestry as a predictor of haemodynamic profile in heart failure
   Sabrina Bernardez-Pereira et al, 2016, Open Heart CrossRef
8. Pharmacogenomics of Heart Failure: a Systematic Review
   Fannie Mottet et al, 2016, Pharmacogenomics CrossRef
9. Race, Common Genetic Variation, and Therapeutic Response Disparities in Heart Failure
   Mathew R. Taylor et al, 2014, JACC: Heart Failure CrossRef
10. Practical Pharmacogenomic Approaches to Heart Failure Therapeutics
    Chayakrit Krittanawong et al, 2016, Current Treatment Options in Cardiovascular Medicine CrossRef
11. O Polimorfismo Genético do Receptor Beta-Adrenérgico Tipo 1 Ser49Gly é Preditor de Morte em Pacientes Brasileiros com Insuficiência Cardíaca
    Felipe Neves de Albuquerque et al, 2020, Arquivos Brasileiros de Cardiologia CrossRef
12. Androgen Deprivation Therapy Use Increases the Risk of Heart Failure in Patients With Prostate Cancer: A Population‐Based Cohort Study
    Hui‐Han Kao et al, 2019, The Journal of Clinical Pharmacology CrossRef
13. The role of the renin-angiotensin system gene polymorphisms in the development of carbohydrate disorders in patients with arterial hypertension
    L. V. Zhuravlyova et al, 2019, The Siberian Medical Journal CrossRef
14. Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery
    Sisi Dai et al, 2021, Clinical Therapeutics CrossRef
15. Overview of the impact β1-adrenergic receptor gene polymorphisms have on the progression of heart failure
    Iurii Rudyk et al, 2019, JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE CrossRef
16. G protein, phosphorylated-GATA4 and VEGF expression in the hearts of transgenic mice overexpressing β1- and β2-adrenergic receptors
    Hyun-Jin Tae et al, 2017, Molecular Medicine Reports CrossRef
17. Ser49Gly polymorphism in the β-adrenergic receptor 1 gene in a population sample from Rio de Janeiro state, Brazil, stratified by self-identified skin color and genetic ancestry
    KELLY T. SANTOS et al, 2015, Molecular Medicine Reports CrossRef